Furthermore, XBP1 administration in the hippocampus restores the content of synaptic proteins, suggesting the therapeutic potentiality of spliced XBP1 to alleviate AD neuropathology (Duran-Aniotz et al., 2023). This evidence concerns the gene XBP1 and Alzheimer disease.